DexCom (DXCM)
DexCom Beneish M-Score: -2.450
View DXCM Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
DXCM Beneish M-Score Rankings
| Overall | 36th percentile | 2388 of 3761 |
| Sector | 43rd percentile | 193 of 342 in Healthcare |
| Industry | 27th percentile | 45 of 62 in Medical Instruments & Supplies |
DXCM Beneish M-Score Range, Past 5 Years
| Minimum | -2.813 | Dec 2010 |
| Maximum | -2.450 | Dec 2011 |
| Average | -2.692 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these DXCM related companies
DXCM News
Listen to $DXCM at deutsche bank ag health care conference - live at 09:20 AM, ondemand after - http://stks.co/3iYr
about 21 days ago by earningscast
about 21 days ago by earningscast
Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now
May 03, 9:54AM Street Insider
May 03, 9:54AM Street Insider
Dexcom to Present at the Deutsche Bank 37th Annual Healthcare Conference
Apr 26, 8:30AM Business Wire
Apr 26, 8:30AM Business Wire
Dexcom Schedules First Quarter 2012 Earnings Release and Conference Call for May 2, 2012
Apr 25, 8:30AM Business Wire
Apr 25, 8:30AM Business Wire
Leerink Swann Starts DexCom (DXCM) at Market Perform; Positive Long-Term, But Some Near-Term Hurdles
Apr 02, 7:52AM Street Insider
Apr 02, 7:52AM Street Insider
$DXCM forms bullish "Continuation Wedge" chart pattern. http://stks.co/2tRo
about 74 days ago by RecogniaEvents
about 74 days ago by RecogniaEvents
Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Solid Q4 & Conservative Guidance
Feb 24, 10:40AM Street Insider
Feb 24, 10:40AM Street Insider
Brean Murray Carret Raises Price Target on DexCom (DXCM), Strong Potential with Gen4 and SweetSpot
Feb 24, 10:18AM Street Insider
Feb 24, 10:18AM Street Insider
RT @ChartSwingTrade Potential earning movers tomorrow based on charts - $BOOM $UEIC $DXCM $AXTI $OVTI $SD Many earnings moves today faded
about 95 days ago by 1973Hog
about 95 days ago by 1973Hog
Listen to $DXCM Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOD
about 95 days ago by earningscast
about 95 days ago by earningscast
$DXCM Reports Q4 EPS $(0.18) vs $(0.17) Est; Revenues $22.40M vs $21.63M Est
about 95 days ago by Benzinga
about 95 days ago by Benzinga
DexCom, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:05PM Business Wire
Feb 23, 4:05PM Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2011 Earnings Release and Conference Call for February 23, 2012
Feb 14, 9:05AM Business Wire
Feb 14, 9:05AM Business Wire
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Feb 07, 8:39AM Street Insider
Feb 07, 8:39AM Street Insider
DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement
Feb 02, 8:30AM Business Wire
Feb 02, 8:30AM Business Wire
...would not hurt them if the market pulls back a bit here. The patterns look very good however. $ACOM $DXCM $CROX $STMP
about 132 days ago by ChartSwingTrade
about 132 days ago by ChartSwingTrade
$ACOM $DXCM $CROX $STMP - all forming VERY nice flag patterns here and are probably my favorite candidates this week. A little more rest...
about 132 days ago by ChartSwingTrade
about 132 days ago by ChartSwingTrade
Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead
Jan 17, 7:30AM Street Insider
Jan 17, 7:30AM Street Insider
All I want for the New Year is for most of my daily charts to look like $DXCM, what a lovely thing.
about 151 days ago by jstajrk2
about 151 days ago by jstajrk2
$DXCM http://stks.co/1iMQ from watch list is into the gap but vol so far only 23% of ave full day
about 152 days ago by StockTiger
about 152 days ago by StockTiger
$DXCM http://stks.co/1eRW 50-day is at $8.75 so over that on good volume
about 159 days ago by StockTiger
about 159 days ago by StockTiger
$DXCM http://stks.co/1da1 Nice move yest on +volume. Sitting on 50d and top of recent range.
about 160 days ago by TER_Intraday
about 160 days ago by TER_Intraday
EBR Watchlist/worksheet/3 Trading Ideas: $GOOG $VCHC $TZOO $GMCR $DXCM http://stks.co/1dZo
about 160 days ago by TER_Intraday
about 160 days ago by TER_Intraday
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DXCM | 10.79 | +0.30 | +2.86% | 729.73M |
| DX | 9.35 | +0.03 | +0.32% | 506.02M |
| DWX | 42.82 | -0.02 | -0.05% | |
| DWSN | 24.95 | +0.07 | +0.28% | 197.60M |
| DSX | 8.25 | +0.27 | +3.38% | 681.20M |
| DSW | 61.17 | -0.22 | -0.36% | 2.682B |
| DSUM | 23.85 | -0.03 | -0.13% | |
| DSU | 4.12 | +0.10 | +2.49% | |
| DSTI | 1.09 | +0.08 | +7.92% | 1.504M |
| DST | 51.79 | -0.68 | -1.30% | 2.307B |